Krill-IQ Launched by Mercola Containing Enzymotec's Nutrients
"Besides the phosphatidylserine and omega-3 which are knows and acceptable brain nutrients, we have also added our alpha-GPC active, an Enzymotec exclusive grade." Says Elzaphan Hotam, CEO of Enzymotec USA.
5/4/2011 --- Krill-IQ has introduced for the first time a unique and potent combination of phosphatidylserine derived from Antarctic krill, krill oil, containing omega-3 and Astaxanthin and alpha-GPC, all are exclusive nutrients of Enzymotec.
"This launch is a result of almost 2 years of joint efforts to bring consumers the most advanced Krill-derived brain product. This new product features for the first time PS derived from Antarctic Krill-in which both EPA and DHA are conjugated together on the same phospholipids. The product also contains high levels of Omega-3/Astaxanthin Complex which is originated exclusively from Krill biomass. Besides the phosphatidylserine and omega-3 which are knows and acceptable brain nutrients, we have also added our alpha-GPC active, an Enzymotec exclusive grade." Says Elzaphan Hotam, CEO of Enzymotec USA. "We believe this innovative approach to brain health and krill oil is only the beginning of what our companies can do together in the fields of health and nutrition," concludes Elzaphan.
Mercola’s Krill-IQ brings together multiple important elements: Phosphatidlyserine which was shown to support brain cell and nerve cell function, antioxidants and omega-3 fatty acids to help protect against long-term effects of oxidation and inflammation and GPC that may provide both short-term and long-term effects with solid scientific rationale – for healthy brain functions.
Mercola’s website is the number one of the most visited natural health site on the Internet. Mercola’s widespread visibility promises to offer exceptional exposure for this revolutionary new product.
Enzymotec is a dynamic biotech company and a leading global developer, producer and supplier of lipid-based products and solutions. Enzymotec develops, manufactures and markets innovative BioActive ingredients and finished products based on sophisticated proprietary technologies. Enzymotec's products support general health, from cardiovascular to cognitive functions, in the largest therapeutic markets and deliver innovative solutions in three business segments:
1) VAYA Pharma – a research-based, specialty pharmaceutical division, dedicated to the discovery , development, manufacture and marketing of innovative, clinically tested, effective and safe lipids based medicines.
2) Infant Nutrition -Providing lipid compositions that mimic the fat in human milk for the wellbeing of infants
3) BioActive Ingredients – Providing premium innovative bioactive ingredients tailored to suit unique needs of pharmaceutical and nutrition industries.
